Drugs / 23-valent pneumococcal vaccine
last change Jan 2015 re-read 2 minutes ago

23-valent pneumococcal vaccine

Vaccine

Developed for
pneumonia
Investigated by
Memorial Sloan Kettering Cancer Center · Naval Health Research Center · U.S. Army Medical Research and Development Command

Trials 2 · a red edge is where a trial was stopped

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00741039 Aug 2008 → Aug 2012 breast cancer, lung cancer, prostate cancer Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 41 trial
Phase 4 NCT02079701 Oct 2000 → Jun 2003 pneumonia Naval Health Research Center Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00279734 Background Aug 2004 → Jan 2005 rheumatoid arthritis Bristol-Myers Squibb Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as 23-valent pneumococcal vaccine “the 23-valent pneumococcal vaccine (0.5 ml subcutaneously or intramuscularly)” NCT00741039
2

“the intramuscular 23-valent pneumococcal vaccinePMID 17425783 2007

NCT02079701

Known as 23-valent polysaccharide pneumococcal vaccine “This study evaluated the effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV23) in reducing pneumonia in healthy military trainees.” PMID 25579777 Jan 2015
Known as Pneumovax “PPV23 vaccine (Pneumovax), (0.5 ml subcutaneously or intramuscularly)” NCT00741039
Known as PPV23 “This study evaluated the effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV23) in reducing pneumonia in healthy military trainees.” PMID 25579777 Jan 2015
Known as PPV23 vaccine PPV23 vaccine (Pneumovax), (0.5 ml subcutaneously or intramuscularly)” NCT00741039
Modality Vaccine “the intramuscular 23-valent pneumococcal vaccinePMID 17425783 2007
Route Intramuscular “the intramuscular 23-valent pneumococcal vaccine” PMID 17425783 2007